India, June 13 -- image credit- shutterstock

Raichur-based Shilpa Biocare Private Limited, a fully-owned subsidiary ofShilpa Medicare Limited, has secured a Europe-wide commercial supply agreement withOrion Corporationfor Recombinant Human Albumin.

Shilpa's Recombinant Human Albumin - a key plasma protein used in various therapeutic applications - is currently under development and will be manufactured using a robust non-human expression system. This provides improved safety, scalability, and virus-free production, addressing some of the key limitations associated with human-derived albumin.

Under the terms of the agreement, Orion will gain exclusive rights to distribute, market and sell Shilpa's Recombinant Human Albumin in Europe, wi...